Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings in Brief: Oct. 17, 2013

AltheRx, AMAG, Discovery Labs, EMD Serono, Pfizer, Relypsa, Savara, Vertex

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II Relypsa HKL treatment reduces serum potassium . . . read more Savara receives CFFT grant for inhaled antibiotic . . . read more Phase III Huge R&D update from Vertex . . . read more Filings AltheRx gets patent for OAB combination . . . read more AMAG PDUFA date delayed . . . read more Discovery Labs files IND for Aerosurf . . . read more EMD Serono Gonal-F injector pen approved . . . read more Pfizer get expanded Prevnar 13 label in EU . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters